| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 66.59× | 66.59× | 69.24× | 62.60× | 67.08× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 3.13× | 3.26× | 3.89× | 6.46× | 5.02× | ||
| 0.91× | 0.91× | 0.92× | 0.90× | 0.91× | ||
| 1.34× | 1.34× | 1.05× | 1.35× | 0.35× | ||
| 0.93× | 0.93× | 0.72× | 0.83× | 0.23× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/09/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 67.08 | 62.60 | 69.24 | 66.59 | 66.59 | |
| Working Capital Turnover | 5.02 | 6.46 | 3.89 | 3.26 | 3.13 | |
| Asset Turnover | 0.91 | 0.90 | 0.92 | 0.91 | 0.91 | |
| Cash Conversion (CFO/Net Income) | 0.35 | 1.35 | 1.05 | 1.34 | 1.34 | |
| CFO/EBITDA | 0.23 | 0.83 | 0.72 | 0.93 | 0.93 |